Αποτελέσματα Αναζήτησης
2 Μαΐ 2022 · New York Medical Treatment Guidelines, Effective May 2, 2022. Below are new editions of the New York Medical Treatment Guidelines effective for dates of treatment on or after May 2, 2022. New York Ankle and Foot Disorders. New York Elbow Injuries.
A. General Guideline Principles. The principles summarized in this section are key to the intended application of the New York State Medical Treatment Guidelines (MTG) and are applicable to all Workers’ Compensation Medical Treatment Guidelines.
The Chair has adopted amendments to 12 NYCRR 324.2, incorporating three new New York Medical Treatment Guidelines (MTGs) by reference: New York Eye Disorders Medical Treatment Guidelines. New York Traumatic Brain Injury Medical Treatment Guidelines.
3 Σεπ 2024 · ACLS guidelines: Loading dose: Infuse 20 mg/minute (up to 50 mg/minute for more urgent situations) until arrhythmia is controlled, hypotension occurs, QRS complex widens by 50% of its original width, or total of 17 mg/kg is given.
8 Μαΐ 2023 · Procainamide is a medication used to manage and treat ventricular arrhythmias, supraventricular arrhythmias, atrial flutter, atrial fibrillation, AV nodal re-entrant tachycardia, and Wolf-Parkinson-White syndrome. It is a Class 1A antiarrhythmic agent.
In ACLS, procainamide is indicated for the treatment of stable ventricular tachycardia. However, it can also be used in the treatment of AF with RVR including AF caused by WPW. The main side effect of procainamide is hypotension due to decreased inotropy.
First dose: 6 mg rapid IV push; follow with NS flush. Second dose: 12 mg if required. Antiarrhythmic Infusions for Stable Wide-QRS Tachycardia Procainamide IV dose: 20-50 mg/min until arrhythmia suppressed, hypotension ensues, QRS duration increases >50%, or maximum dose 17 mg/kg given.
